Search Results - "Codrington, H"

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study by AERTS, J. G, CODRINGTON, H, LANKHEET, N. A. G, BURGERS, S, BIESMA, B, DINGEMANS, A. -M. C, VINCENT, A. D, DALESIO, O, GROEN, H. J. M, SMIT, E. F

“…Epidermal growth factor receptor tyrosine kinase inhibitors (TKIs) administered concurrently with chemotherapy did not improve outcome in non-small-cell lung…”
Get full text

3059 Influence of an acidic beverage (Coca-Cola) on the absorption of erlotinib: Results of a cross-over study in NSCLC patients by Van Leeuwen, R, Peric, R, Hussaarts, K, Kienhuis, E, IJzerman, N, Bruijn, P. De, Van der Leest, K, Codrington, H, Kloover, J, Van der Holt, B, Aerts, J, Van Gelder, T, Mathijssen, R

Get full text

OC-0498 CONCURRENT CHEMORADIOTHERAPY WITH OR WITHOUT CETUXIMAB IN NSCLC; TOXICITY RESULTS OF A RANDOMIZED PHASE II TRIAL by Belderbos, J, Uyterlinde, W, Vincent, A, Aerts, J, Codrington, H, van de Vaart, P, Kunst, P, Dieleman, E, Verheij, M, van den Heuvel, M

Get full text

Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy by Schouwink, J.H, Codrington, H, Sleeboom, H.P, Kerkhofs, L.G.M, Wormhoudt, L.W

“…Abstract This study compared the effects of early intervention with standard use of epoetin alfa on haemoglobin (Hb) levels and transfusion requirements in…”
Get full text

Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four cases by Herder, Gjm, Codrington, H, Colder, C D, Aerts, J G

“…Previous research showed that the addition of bevacizumab (a monoclonal antibody against vascular endothelial growth factor [VEGF]) to chemotherapy resulted in…”
Get full text

1122 POSTER Prevention of anemia by early intervention with once weekly epoetin alfa during chemotherapy by Codrington, H, Schouwink, J.H, Sleeboom, H.P, Kerkhofs, L.G.M, Wormhoudt, L.W

Get full text

Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: an observational study by Storm, B., Abedian Kalkhoran, H., Wilms, E., Brocken, P., Codrington, H., Houtsma, D., Portielje, J., de Glas, N., van der Ziel, D., van den Bos, F., Visser, L.

Get full text

SIOG2021-0048 - Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: an observational study by Storm, B., Abedian Kalkhoran, H., Wilms, E., Brocken, P., Codrington, H., Houtsma, D., Portielje, J., de Glas, N., van der Ziel, D., van den Bos, F., Visser, L.

Get full text

P057 - LOW RATE OF TOXICITY IN OLDER CANCER PATIENTS TREATED WITH IMMUNOTHERAPY by Van Der Ziel, D., De Glas, N., Storm, B., Bastiaannet, E., Visser, L., Wilms, E., Codrington, H., Houtsma, D., Portielje, J., Van Den Bos, F.

Get full text

LOW RATE OF TOXICITY IN OLDER CANCER PATIENTS TREATED WITH IMMUNOTHERAPY by Van Der Ziel, D., De Glas, N., Storm, B., Bastiaannet, E., Visser, L., Wilms, E., Codrington, H., Houtsma, D., Portielje, J., Van Den Bos, F.

Get full text

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study††Presented as oral presentation at ESMO 2012 in Vienna Austria by Aerts, J.G., Codrington, H., Lankheet, N.A.G., Burgers, S., Biesma, B., Dingemans, A.-M.C., Vincent, A.D., Dalesio, O., Groen, H.J.M., Smit, E.F.

“…Epidermal growth factor receptor tyrosine kinase inhibitors (TKIs) administered concurrently with chemotherapy did not improve outcome in non-small-cell lung…”
Get full text

A Randomized Phase II Study Comparing Erlotinib (E) Versus e Alternating with Chemotherapy in Relapsed Non-Small Cell Lung Cancer (NSCLC) Patients. The NVALT10 Study by Aerts, J.G., Codrington, H., Burgers, S., Biesma, B., Dalesio, O., Dingemans, A.C., Vincent, A.D., Groen, H.J.M., Smit, E.F.

Get full text

Autofluorescence bronchoscopy improves staging of radiographically occult lung cancer and has an impact on therapeutic strategy by Sutedja, T G, Codrington, H, Risse, E K, Breuer, R H, van Mourik, J C, Golding, R P, Postmus, P E

“…The ability of conventional CT scans and fiberoptic bronchoscopy to localize and properly stage radiographically occult lung cancer (ROLC) in the major airways…”
Get more information

THE HEAVENLY ALTAR AND THE EPICLESIS IN EGYPT by Codrington, H. W.

Get full text

A Gold Coin (Dinar) of Mustanjid by Codrington, H. W.

Get full text

Karsa, Karsapana by Codrington, H. W.

Get full text

THE PERSIAN WEIGHT STANDARD IN MEDIAEVAL INDIA by Codrington, H. W.

Get full text

COINS OF SOME KINGS OF HORMUZ by Codrington, H. W.

Get full text

Does life add years to life? Clinical outcome in using autofluorescence bronchoscopy for occult cancers by Codrington, H, Postmus, P.E, Sutedja, G

Get full text

Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer by van Putten, John W.G, Baas, Paul, Codrington, Henk, Kwa, Hian-Bie, Muller, Martin, Aaronson, Neil, Groen, Harry J.M

“…The aim of the study was to evaluate activity, toxicity and health-related quality of life (HRQL) with gemcitabine as second-line treatment after previous…”
Get full text